Neuromodulation Market Analysis by Technology (Internal, External), by Application (Deep Brain Simulation, Spinal Cord Simulation, Sacral Nerve Simulation, Gastric Electrical Simulation) and by Region - Forecast to 2029

Request Sample Page

The global neuromodulation market size is estimated to be USD 5,986.6 million in 2021 and is expected to witness a CAGR of 8.83% during the forecast period. Prevalence and increase in the number of neurological disorders cases is a key driver responsible for the growth of the global neuromodulation market. Additionally, research into expanding the applications of neuromodulation, rising awareness about neurodegenerative disorders, and growing share of OTC drugs in the market for self-medication are some of the other drivers propelling the market growth. Nevertheless, high cost of neuromodulation procedures and shortage of trained professionals are expected to restrain the global market growth.

Global Neuromodulation Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Technology

Based on technology, the market is divided into internal and external neuromodulation. In 2021, the internal neuromodulation segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the application of spinal cord stimulation in the treatment of widespread chronic back pain worldwide. Deep brain stimulation, which a subsegment of the internal neuromodulation segment, is projected to grow at a profitable CAGR during the forecast period. This is due to increasing adoption of neuromodulation in developed economies for the treatment of neurological disorders such as Parkinson’s disease, which have no known cure.

By Application

Based on application, the market is segmented into the deep brain, spinal cord, sacral nerve, gastric electrical stimulation, vagus nerve, transcutaneous electrical nerve, transcranial magnetic, and respiratory electrical stimulation. In 2021, the deep brain stimulation segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the rising incidence of Parkinson’s disease and growing R&D activity in this area worldwide. The spinal cord stimulation segment is projected to grow at a profitable CAGR during the forecast period. This is due to its expanding application across various segments including failed-back surgery syndrome, peripheral vascular disease, and complex regional pain syndrome.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of leading market players, major pharmaceutical and biopharmaceutical industries, preferences by new market players, along with the rise in investments in the region for the adoption of advanced technologies. Asia Pacific market is projected to grow at the fastest CAGR over the forecast period owing to the high incidence of neurological disorders, growing awareness about mental health, increasing public and private investments, and ongoing research.

Competitor Insights

Some of the major companies in the neuromodulation market are Medtronic (Ireland); Boston Scientific Corporation (U.S.); Abbott Laboratories (U.S.); LivaNova (U.K.); Synapse Biomedical (U.S.); Nevro Corporation (U.S.); NeuroSigma (U.S.); NeuroPace (U.S.); Neuronetics (U.S.); and BioControl Medical (Israel). Investment in R&D, novel product launches, and strategic collaborations & acquisitions are some of the major strategies adopted by the leading players operating in the industry.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The neuromodulation market report is categorized into the following segments and subsegments:

Neuromodulation Market, By Technology (Revenue, 2021-2029, USD Million)

  • Internal Neuromodulation
    • Deep Brain Stimulation
    • Spinal Cord Stimulation
    • Vagus Nerve Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
  • External Neuromodulation
    • Transcranial Magnetic Stimulation
    • Transcutaneous Electrical Nerve Stimulation
    • Respiratory Electrical Stimulation

Neuromodulation Market, By Application (Revenue, 2021-2029, USD Million)

  • Deep Brain Stimulation
    • Parkinson’s Disease
    • Tremors
    • Depression
    • Other Dbs Applications
  • Spinal Cord Stimulation
    • Chronic Pain
    • Failed Back Surgery Syndrome
    • Ischemia
  • Sacral Nerve Stimulation
    • Urinary Incontinence
    • Fecal Incontinence
  • Gastric Electrical Stimulation
    • Gastroparesis
    • Obesity
  • Vagus Nerve Stimulation
    • Epilepsy
  • Transcutaneous Electrical Nerve Stimulation
    • Treatment-Resistant Depression
  • Transcranial Magnetic Stimulation
    • Depression
    • Migraine
  • Respiratory Electrical Stimulation
    • Spinal Cord Injury

Neuromodulation Market, By Region (Revenue, 2021-2029, USD Million)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Neuromodulation Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Neuromodulation Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Neuromodulation
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Neuromodulation Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Technology
    1. Internal Neuromodulation
      1. Internal Neuromodulation Market Forecast, 2021-2029 (USD Million)
    2. External Neuromodulation
      1. External Neuromodulation Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Deep Brain Stimulation
      1. Deep Brain Stimulation Market Forecast, 2021-2029 (USD Million)
    2. Spinal Cord Stimulation
      1. Spinal Cord Stimulation Market Forecast, 2021-2029 (USD Million)
    3. Sacral Nerve Stimulation
      1. Sacral Nerve Stimulation Market Forecast, 2021-2029 (USD Million)
    4. Gastric Electrical Stimulation
      1. Gastric Electrical Stimulation Market Forecast, 2021-2029 (USD Million)
    5. Vagus Nerve Stimulation
      1. Vagus Nerve Stimulation Market Forecast, 2021-2029 (USD Million)
    6. Transcutaneous Electrical Nerve Stimulation
      1. Transcutaneous Electrical Nerve Stimulation Market Forecast, 2021-2029 (USD Million)
    7. Transcranial Magnetic Stimulation
      1. Transcranial Magnetic Stimulation Market Forecast, 2021-2029 (USD Million)
    8. Respiratory Electrical Stimulation
      1. Respiratory Electrical Stimulation Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Neuromodulation Market
    1. North America Neuromodulation Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. S. Neuromodulation Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Canada Neuromodulation Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Europe Neuromodulation Market
    1. Europe Neuromodulation Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Germany Neuromodulation Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. UK Neuromodulation Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. France Neuromodulation Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Spain Neuromodulation Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              2. Italy Neuromodulation Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Europe Neuromodulation Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Asia Pacific Neuromodulation Market
    1. Asia Pacific Neuromodulation Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Japan Neuromodulation Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. China Neuromodulation Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. India Neuromodulation Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. South Korea Neuromodulation Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia Neuromodulation Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Neuromodulation Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Latin America Neuromodulation Market
    1. Latin America Neuromodulation Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Brazil Neuromodulation Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Mexico Neuromodulation Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Argentina Neuromodulation Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Rest of Latin America Neuromodulation Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. MEA Neuromodulation Market
    1. MEA Neuromodulation Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. GCC Neuromodulation Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. South Africa Neuromodulation Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Rest of MEA Neuromodulation Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Medtronic (Ireland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    2. Boston Scientific Corporation (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    3. Abbott Laboratories (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    4. LivaNova (U.K.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    5. Synapse Biomedical (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    6. Nevro Corporation (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    7. NeuroSigma (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    8. NeuroPace (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    9. Neuronetics (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    10. BioControl Medical (Israel)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports